Michael A. Mussallem - Jan 13, 2023 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role
Chairman & CEO, Director
Signature
Linda J. Park, Attorney-in-Fact
Stock symbol
EW
Transactions as of
Jan 13, 2023
Transactions value $
-$518,221
Form type
4
Date filed
1/13/2023, 05:41 PM
Previous filing
Dec 14, 2022
Next filing
Feb 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Options Exercise $1.03M +29.4K +18.67% $35.20 187K Jan 13, 2023 Direct F1
transaction EW Common Stock Gift $0 -9.5K -5.09% $0.00 177K Jan 13, 2023 Direct
transaction EW Common Stock Sale -$1.55M -19.9K -11.21% $78.09 157K Jan 13, 2023 Direct F1, F2
transaction EW Common Stock Gift $0 +9.5K +0.27% $0.00 3.48M Jan 13, 2023 By Living Trust
holding EW Common Stock 372K Jan 13, 2023 401(k)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Employee Stock Option (Right to Acquire) Options Exercise $0 -29.4K -20% $0.00 118K Jan 13, 2023 Common Stock 29.4K $35.20 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022.
F2 This transaction was executed in multiple trades at prices ranging from $77.43 to $78.40 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.